These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29540332)

  • 21. Hypersensitivity reactions to gadolinium-based contrast agents.
    Fok JS; Smith WB
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic-like Reactions to the MR Imaging Contrast Agent Gadobutrol: A Prospective Study of 32 991 Consecutive Injections.
    Power S; Talbot N; Kucharczyk W; Mandell DM
    Radiology; 2016 Oct; 281(1):72-7. PubMed ID: 27110731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients.
    Ahn YH; Kang DY; Park SB; Kim HH; Kim HJ; Park GY; Yoon SH; Choi YH; Lee SY; Kang HR
    Radiology; 2022 May; 303(2):329-336. PubMed ID: 35191737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions.
    Costello JR; Kalb B; Martin DR
    Top Magn Reson Imaging; 2016 Dec; 25(6):257-263. PubMed ID: 27748714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract]   [Full Text] [Related]  

  • 27. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
    Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
    Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypersensitivity to contrast media and dyes.
    Brockow K; Sánchez-Borges M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):547-64, viii. PubMed ID: 25017677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.
    Murphy KJ; Hansen R; Prince MR
    AJR Am J Roentgenol; 1997 Jul; 169(1):318-9. PubMed ID: 9207574
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Contrast Media.
    Rosado Ingelmo A; Doña Diaz I; Cabañas Moreno R; Moya Quesada MC; García-Avilés C; García Nuñez I; Martínez Tadeo JI; Mielgo Ballesteros R; Ortega-Rodríguez N; Padial Vilchez MA; Sánchez-Morillas L; Vila Albelda C; Moreno Rodilla E; Torres Jaén MJ
    J Investig Allergol Clin Immunol; 2016; 26(3):144-55; quiz 2 p following 155. PubMed ID: 27326981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
    Behzadi AH; Zhao Y; Farooq Z; Prince MR
    Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse reactions following administration of contrast media for diagnostic imaging in anaesthetized dogs and cats: a retrospective study.
    Scarabelli S; Cripps P; Rioja E; Alderson B
    Vet Anaesth Analg; 2016 Sep; 43(5):502-10. PubMed ID: 26782994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.
    Briguori C; Colombo A; Airoldi F; Melzi G; Michev I; Carlino M; Montorfano M; Chieffo A; Bellanca R; Ricciardelli B
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):175-80. PubMed ID: 16400668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience.
    Kanal E
    Magn Reson Imaging; 2016 Dec; 34(10):1341-1345. PubMed ID: 27608608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basophil activation test in the diagnosis of gadobutrol anaphylaxis.
    Javaloyes G; Goikoetxea MJ; Sanz ML; Cabrera-Freitag P; Gastaminza G
    Ann Allergy Asthma Immunol; 2012 Apr; 108(4):286-7. PubMed ID: 22469455
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatal Anaphylaxis Associated With the Gadolinium-Based Contrast Agent Gadoteridol (ProHance).
    Takahashi S; Takada A; Saito K; Hara M; Yoneyama K; Nakanishi H
    J Investig Allergol Clin Immunol; 2015; 25(5):366-7. PubMed ID: 26727767
    [No Abstract]   [Full Text] [Related]  

  • 38. Contrast agents for magnetic resonance imaging: safety update.
    Kirchin MA; Runge VM
    Top Magn Reson Imaging; 2003 Oct; 14(5):426-35. PubMed ID: 14625469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with a history of hypersensitivity reaction to iodinated contrast medium and given iodinated contrast during an interventional pain procedure.
    Benzon HT; Schechtman J; Zheng SC; Katz JA; Patel A; Nagpal G; Liu BP
    Reg Anesth Pain Med; 2019 Jan; 44(1):118-121. PubMed ID: 30640663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.